Latest Regulatory News

Optiscan Imaging has reached the halfway recruitment milestone in its first in-human breast cancer study, advancing its regulatory and commercial ambitions with promising clinical data and expanded trial sites.

PMET Resources has received a non-binding Letter of Interest from Société Générale to act as Mandated Lead Arranger for debt financing of the Phase 1 development of its Shaakichiuwaanaan lithium project in Quebec, advancing its syndicate-building strategy ahead of an updated feasibility study.

Chalice Mining has outlined a compelling 2.5km copper-molybdenum-silver soil anomaly near Goomalling, WA, featuring rock chips with over 15% total rare earth oxides and strategic magnet rare earths. An initial drilling program is imminent.

DPM Metals has revealed a major new gold-copper porphyry discovery at its Brevene South Porphyry target adjacent to the Chelopech mine, with drill results showing broad intervals of high-grade mineralization and plans for an intensive follow-up drilling campaign.

Diamond Infraco 1 Pty Ltd, the IFM Global Infrastructure Fund subsidiary, has pushed back the closing date for its Atlas Arteria takeover offer to 18 June 2026. None of the offer conditions have been met yet, prolonging uncertainty around the bid’s completion.

Matrix Composites & Engineering has secured Federal Court approval to hold a shareholder meeting on 6 July 2026 to vote on Advanced Innergy's full acquisition scheme. The court also approved the release of a Scheme Booklet, which includes an Independent Expert's report endorsing the deal as fair and reasonable.

Micro-X has captured the first human head images using its innovative carbon nanotube cone beam CT technology, marking a major technical milestone as it launches a multi-centre pilot study aimed at stroke diagnosis.

Elanor Investors Group appoints David McNamara as CEO, signaling a leadership shift following a balance sheet recapitalisation and strategic reset. The Board also sees key transitions with Tony Fehon moving to a non-executive role and Su Kiat Lim stepping down.

Sky Metals has secured a crucial regulatory milestone for its Tallebung tin-silver-tungsten project in NSW, moving into the Environmental Impact Statement phase following the issuance of SEARs by the NSW Department of Planning. The company prepares for imminent resource and feasibility updates that could shape the project’s development trajectory.

Ampol's acquisition of EG Australia has gained ACCC approval, conditional on divesting 41 overlapping fuel sites to Metro Petroleum to preserve competition in 39 local markets.

The ACCC has approved Ampol’s acquisition of EG Australia, mandating the sale of 41 overlapping fuel retail sites to Metro Petroleum to maintain competition across 39 local markets.

Cynata Therapeutics secures a crucial regulatory green light from the EMA’s Paediatric Committee for its CYP-001 treatment in children with acute graft versus host disease, paving the way for sequential adult and paediatric trials in Europe.